NEW YORK, March 31, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Platform Specialty Products Corporation (“Platform”) (NYSE:PAH) between February 17, 2015 and March 14, 2016.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of Florida. If you purchased or otherwise acquired Platform securities between February 17, 2015 and March 14, 2016, your rights may be affected by this action. To get more information go to: http://www.zlk.com/pslra/platform-specialty-products-corporation.
On February 17, 2015, Platform completed its acquisition of Arysta LifeScience Limited. The complaint alleges that throughout the Class Period defendants issued false and misleading statements to investors and/or failed to disclose that: (1) Arysta made improper third-party payments in West Africa; (2) such payments were unlawful under the U.S. Foreign Corrupt Practices Act; and (3) as a result, Platforms’ public statements were materially false and misleading at all relevant times.
If you suffered a loss in Platform you have until June 1, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/pslra/platform-specialty-products-corporation.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban
Hermès Q1 2026 Sales Miss Expectations Amid Iran War and China Slowdown
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit
Anthropic Nears $800 Billion Valuation as Investor Confidence Surges
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring 



